Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat nasopharyngeal carcinoma Read more
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate Read more
Informing payers and patients of biological therapy advantages can strengthen biosimilars market Read more